Clinicians have often pondered if cancer cells could be selectively targeted, and how payloads ranging from fluorescent dyes to oncology drugs could be accurately delivered to these cells, and then safely cleared through the kidneys. Now, researchers at Memorial Sloan Kettering Cancer Center, and Nanotechnology in the College of Engineering at Cornell University have found the answer in the form of a new class of ultra-small nanoparticles that are showing significant potential for cancer diagnosis and treatment, and positive results in pre-clinical and clinical trials.
Researchers are finding that the use of new ultra-small nanoparticles called C-dots allows improved visualization in Positron Emission Tomography (PET) scans for diagnosis and real-time image-guided intraoperative mapping of nodal metastases to aid in precise surgical excision, currently in Phase II human clinical trials.
These ultra-small particles can also serve as a precision therapeutic solution, targeting and penetrating cancer cells to deliver a range of cancer-killing drugs, with the promise of unused particles and the drugs they carry safely leaving the body through the renal system.
The architecture of the C-dot is an ultra-small silica nanoparticle with a diameter of less than 10 nanometers, first innovated at Cornell University by Ulrich Wiesner, the Spencer T. Olin Professor of Engineering. Silica, also known as silicon dioxide (SiO2), is a widely existing inorganic composition which can be found in many places, e.g. plants, cosmetics, medicine and food such as bread crust.
Multiple near infrared (near-IR) fluorescent dye molecules can be covalently encapsulated inside the silica particle, and the fluorescence brightness of these molecules is further enhanced by the rigid surrounding silica matrix. As a result, the overall fluorescence brightness of C-dots can be one order of magnitude higher than that of dyes alone, delivering new capabilities to surgeons. Meanwhile, the surface of C-dots is covalently covered with polymer chains to increase bio-compatibility. Due to the high versatility of the synthesis chemistry of C-dots, different functional ligands can be selectively attached to the end of some of the polymer chains on the C-dot surface to endow the particles with a variety of functionalities for different applications, including, but not limited to cancer targeting, radio-isotopes chelating, and small molecule drug delivery.
Importantly, the ultra-small hydrodynamic size of C-dots enable them to be efficiently cleared from the body through the renal system.
Image Credit: Elucida Oncology
News This Week
A red-hot anti-aging strategy quietly passed its first test earlier this year after 14 volunteers took drugs meant to kill off old, toxic cells in their bodies. The small study in people with [...]
Since the discovery of biological ion channels and their role in physiology, scientists have attempted to create man-made structures that mimic their biological counterparts. New research by Lawrence Livermore National Laboratory (LLNL) scientists and [...]
Sometimes it is too cold for us and then too warm again - annoying dressing-undressing of sweaters and co. Is therefore required. However, that may change: researchers have developed a sophisticated textile that can [...]
What is Global Health Care Equivalency (GHCE)? Looking ahead over the next 10-30 years, with the rapid emergence of, and synergies between, the disciplines of nanotechnology, nanomedicine, and AI, we can envisage a future [...]
Researchers in Singapore have built a refrigerator that’s just three atoms big. This quantum fridge won’t keep your drinks cold, but it’s cool proof of physics operating at the smallest scales. The work is [...]
Note: This videoblog is in German. It was produced by the Institute of Art & Art Theory of the University of Cologne. Humanity faces epochal challenges in the age of digitization. In particular, [...]
NanoApps Medical Inc. CEO Frank Boehm has signed with IOP Publishing to produce Nanomedical Brain/Cloud Interface: Explorations and Implications - a book that will explore the notion of a nanomedically enabled Brain/Cloud Interface (B/CI). [...]
Scientists from the University of Bath (UK) and Northwestern University (USA) have developed a new type of sensor platform using a gold nanoparticle array, which is 100 times more sensitive than current similar [...]
Scientists have developed tiny elastic robots that can change shape depending on their surroundings. Modeled after bacteria and fully biocompatible, these robots optimize their movements so as to get to hard-to-reach areas of the [...]
A pea-sized device used to seal tiny but potentially deadly holes in the hearts of premature infants has been approved by U.S. regulators, making it one of the smallest complex medical devices ever invented [...]
Scientists have discovered that squamous cell skin cancers do not require increased glucose to power their development and growth, contrary to a long-held belief about cancer metabolism. The findings could bring about a better [...]
Nanotechnology may well be one of the most talked about industries of the last few years. Predicted to value US$173.95 billion globally by 2025, this fast-moving sector is already delivering major sustainability, health and [...]